CADTH | Evidence Driven
CADTH | Evidence Driven

Off-Label Use of Intravenous Immunoglobulin for Hematological Conditions: Clinical Effectiveness

Details

Files
Project Status:
Completed
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1150-000

Question


  1. What is the clinical effectiveness of the off-label use of intravenous or subcutaneous immunoglobulin for the treatment of hematological conditions?


Key Message

Three systematic reviews (one with meta-analyses), four randomized controlled trials, and four non-randomized studies were identified regarding the clinical effectiveness of the off-label use of intravenous or subcutaneous immunoglobulin for the treatment of hematological conditions.


Files

Off-Label Use of Intravenous Immunoglobulin for Hematological Conditions: Clinical Effectiveness Rapid Response October 24, 2017 View PDF

Related Content

Last Updated : October 24, 2017